SCHEMBL8687765

SCHEMBL8687765

CCCN(C)c1ccc(-c2cnc[nH]2)c(OC)c1OC

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
LTB4R Q15722 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36
EGFR P00533 1/20 0.35
FGFR1 P11362 1/20 0.35
KDR P35968 1/20 0.35
IDO1 P14902 9/20 0.34
ECE1 P42892 1/20 0.34
METAP2 P50579 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8687342 0.91 CYP1A2 (0.40) CYP1A2CYP3A4CYP2D6LTB4RLTB4R2
SCHEMBL8687758 0.89 IDO1 (0.39) CYP1A2CYP3A4CYP2D6EGFRFGFR1
SCHEMBL8687733 0.75 ADRA2A (0.38) CYP1A2CYP3A4CYP2D6IDO1HSP90AA1
SCHEMBL27794554 0.73 ECE1 (0.50) EGFRFGFR1KDRIDO1ECE1
SCHEMBL8687672 0.72 IDO1 (0.48) IDO1
Hydrochloric Acid SCHEMBL28762461 0.72 ECE1 (0.49) EGFRFGFR1KDRIDO1ECE1
SCHEMBL8689417 0.70 IDO1 (0.43) EGFRFGFR1KDRIDO1
SCHEMBL8781118 0.67 MAPK14 (0.39) CYP1A2CYP3A4CYP2D6EGFRFGFR1
SCHEMBL24026598 0.66 IDO1 (0.65) CYP3A4EGFRFGFR1KDRIDO1
SCHEMBL4065993 0.65 ADRA2A (0.50) CYP3A4EGFRFGFR1KDRIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 EP disclosed